Proathlete Wealth Management LLC Novartis Ag Transaction History
Proathlete Wealth Management LLC
- $347 Billion
- Q3 2025
A detailed history of Proathlete Wealth Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Proathlete Wealth Management LLC holds 162 shares of NVS stock, worth $21,311. This represents 0.01% of its overall portfolio holdings.
Number of Shares
162
Previous 175
7.43%
Holding current value
$21,311
Previous $21.2 Million
1.9%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...